Cargando…

Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre

OBJECTIVES: The impact of inhaled corticosteroids (ICS) on eosinophilic inflammation in asthma is well established, but their effect in a real-life setting has not been extensively studied. Our purpose was to investigate the effect of ICS on airway and systemic inflammation as well as on clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demarche, Sophie F, Schleich, Florence N, Henket, Monique A, Paulus, Virginie A, Van Hees, Thierry J, Louis, Renaud E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719334/ https://www.ncbi.nlm.nih.gov/pubmed/29183929 http://dx.doi.org/10.1136/bmjopen-2017-018186

Ejemplares similares

Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory?
por: Demarche, Sophie, et al.
Publicado: (2016)

Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
por: Demarche, Sophie F., et al.
Publicado: (2017)

Revisiting differences between atopic and non-atopic asthmatics: When age is shaping airway inflammatory profile
por: Gerday, Sara, et al.
Publicado: (2022)

A historical perspective: Are inhaled corticoids sufficient to control asthma?
por: Louis, Renaud, et al.
Publicado: (2015)

Predictors of asthma‐related quality of life in a large cohort of asthmatics: A cross‐sectional study in a secondary care center
por: Louis, Gilles, et al.
Publicado: (2021)

Predictors of change in asthma-related quality of life: a longitudinal real-life study in adult asthmatics
por: Louis, Gilles, et al.
Publicado: (2023)

Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation
por: Schleich, Florence N, et al.
Publicado: (2013)

IgE mediated sensitisation to aeroallergens in an asthmatic cohort: relationship with inflammatory phenotypes and disease severity
por: Manise, M., et al.
Publicado: (2016)

Biomarkers in the Management of Difficult Asthma
por: Schleich, Florence, et al.
Publicado: (2016)

Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction – PROMISE
por: Schleich, Florence, et al.
Publicado: (2023)

Reduced sputum expression of interferon-stimulated genes in severe COPD
por: Hilzendeger, Clarissa, et al.
Publicado: (2016)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping
por: Schleich, F., et al.
Publicado: (2021)

Chronic infection with Chlamydia pneumoniae in asthma: a type-2 low infection related phenotype
por: Calmes, Doriane, et al.
Publicado: (2021)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)

Are type-2 biomarkers of any help in asthma diagnosis?
por: Nekoee, Haleh, et al.
Publicado: (2020)

Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis
por: Lokhandwala, Tasneem, et al.
Publicado: (2012)

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
por: Hinds, David R, et al.
Publicado: (2016)

Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review
por: Sonnex, Kimberley, et al.
Publicado: (2020)

Breathomics in Asthmatic Children Treated with Inhaled Corticosteroids
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Are Volatile Organic Compounds Able to Identify Airflow Decline in Asthma?
por: Graff, Sophie, et al.
Publicado: (2021)

Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD
por: Ma, Nan, et al.
Publicado: (2021)

Sputum IgE and Cytokines in Asthma: Relationship with Sputum Cellular Profile
por: Manise, Maïté, et al.
Publicado: (2013)

Study protocol: pneumonia and inhaled corticosteroid treatment patterns in chronic obstructive pulmonary disease – a cohort study using sequence analysis (PICCS)
por: Klitgaard, Allan, et al.
Publicado: (2023)

Adherence to inhaled corticosteroids by asthmatic patients: measurement and modelling
por: Taylor, Amelia, et al.
Publicado: (2013)

Hair cortisol and inhaled corticosteroid use in asthmatic children
por: Baan, Esmé J., et al.
Publicado: (2019)

Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen
por: Zuiker, Rob G. J. A., et al.
Publicado: (2015)

Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis
por: Louis, Gilles, et al.
Publicado: (2023)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids
por: Migueres, Nicolas, et al.
Publicado: (2022)

Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids
por: Butel-Simoes, G.I., et al.
Publicado: (2023)

Atopy and Inhaled Corticosteroid Use Associate with Fewer IL-17(+) Cells in Asthmatic Airways
por: Fattahi, Fatemeh, et al.
Publicado: (2016)

Effect of monitoring adherence to regular inhaled corticosteroid (ICS) alone or in combination with a long-acting β2-agonist (LABA) using electronic methods on asthma outcomes: a narrative systematic review
por: Almutairi, Mohammed, et al.
Publicado: (2023)

Prevalence and severity of asthmatic symptoms in Grenadian school children: the Grenada National Asthma Survey
por: Thongkham, D, et al.
Publicado: (2015)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Impact of corticosteroids in hospitalised COVID-19 patients
por: Ho, Kam Sing, et al.
Publicado: (2021)

Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study
por: Talini, Donatella, et al.
Publicado: (2015)

A simple prediction tool for inhaled corticosteroid response in asthmatic children
por: Wu, Yi-Fan, et al.
Publicado: (2017)

Associations between COVID-19 outcomes and asthmatic patients with inhaled corticosteroid
por: Yong, Su-Boon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3iss1r06bs8c1nsadns1b3esc4